Columbus, Oh-In 2014, we saw the rise of medical kiosks among large-scale drug stores such as Walgreens and CVS. We saw numerous apps surface that served as the “Uber for” doctor visits. But is 2015 the year that telehealth officially takes the stage? With more and more innovation coming from inside and outside the healthcare space, the future of telehealth looks promising.

The need for visiting a physical doctor’s office is rapidly becoming a thing of the past. It’s been found that we are now able to conduct 50% of doctor’s visits and 70% of EMR visits virtually. This opportunity for virtual visitation creates a convenient solution for patients, and our dated system. A system that even doctors are increasingly becoming fed up with.

By 2018: 

  • 65% of healthcare interactions will be done through mobile devices.
  • 70% of healthcare organizations will have apps, wearables, and offer virtual care.

 

Big name celebrities and large-scale venture capitalists have been finding their way into the telehealth space. At CES 2015, Dr. Phil touted his involvement in a new project called Doctor On Demand, which he cofounded with Google, Andreessen Horowitz and Shasta Ventures.


The convenience and support that apps such as Doctor on Demand can provide is lighting the way for a whole new world of telehealth. A world in which you won’t have to feel confined to a rushed 8 minute appointment. A world in which you won’t have to risk catching the flu while you’re in a waiting room trying to find out if you have an ear infection or not.

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.